Related Experiment Video
Updated: Dec 28, 2025

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
Published on: April 25, 2025
Delirium due to the use of topical cyclopentolate hydrochloride
Mahmut Atum1, Erkan Çelik1, Gürsoy Alagöz1
1Sakarya University Education and Research Hospital, Department of Ophthalmology, Sakarya, Turkey.
Insights
Cyclopentolate eye drops can rarely cause delirium in children. Physostigmine is an effective antidote for this rare, severe side effect, rapidly improving symptoms.
Area of Science:
- Ophthalmology
- Pediatric Neurology
- Clinical Toxicology
Background:
- Cyclopentolate is a commonly used anticholinergic mydriatic agent in ophthalmology.
- Systemic side effects, though rare, can occur following ocular instillation.
- Delirium is an uncommon but serious potential adverse reaction.
Observation:
- A 7-year-old child developed acute delirium, including behavioral changes and visual hallucinations, post-cyclopentolate administration.
- Symptoms manifested within 20-25 minutes after the final eye drop.
- The child presented with gait disturbance and significant agitation.
Findings:
- Cyclopentolate instillation can precipitate delirium as a rare systemic anticholinergic toxicity.
- Physostigmine, an acetylcholinesterase inhibitor, was administered intravenously at 0.02 mg/kg.
- Rapid and complete recovery was observed within minutes of physostigmine administration.
Implications:
- Highlights the importance of recognizing delirium as a potential side effect of cyclopentolate in pediatric patients.
- Establishes physostigmine as a crucial and effective antidote for managing severe agitation and delirium caused by cyclopentolate.
- Suggests prompt physostigmine administration for rapid reversal of anticholinergic-induced delirium in pediatric cases.
Abstract:
Introduction - Our aim is to present a rare case where a child had delirium manifestation after instillation of cyclopentolate. Case presentation - A 7-year old patient was seen in our outpatient clinic, and cyclopentolate was dropped three times at 10 minutes intervals in both eyes. The patient suddenly developed behavioral disorders along with gait disturbance, and complained of visual hallucinations 20-25 minutes after the last drop. The patient was transferred to intensive care unit and 0.02 mg/kg IV. physostigmine was administered. The patient improved after minutes of onset of physostigmine, and was discharged with total recovery after 30 minutes. Conclusion - Delirium is a rare systemic side effect of cyclopentolate. The specific antidote is physostigmine, which can be used in severely agitated patients who are not responding to other therapies.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Cholinergic Antagonists: Pharmacokinetics
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Direct-Acting Cholinergic Agonists: Pharmacokinetics

